ciprofloxacin has been researched along with Acinetobacter Infections in 72 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Acinetobacter Infections: Infections with bacteria of the genus ACINETOBACTER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The old antimicrobial nitroxoline is currently repurposed for oral treatment of uncomplicated urinary tract infections (UTIs)." | 4.12 | In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract. ( Becerra-Aparicio, F; Fuchs, F; Higgins, PG; Seifert, H; Xanthopoulou, K, 2022) |
| " The study aimed to investigate the in vitro antibacterial activity of the antidepressants fluoxetine and paroxetine alone and in combination with the antibacterial ciprofloxacin against standard strains and clinical isolates to explore the repositioning of these drugs in severe bacterial infections." | 4.02 | Repositioning of antidepressant drugs and synergistic effect with ciprofloxacin against multidrug-resistant bacteria. ( Bottega, A; da Rosa, TF; de Paula, BR; Foletto, VS; Franco, LN; Hörner, R; Serafin, MB, 2021) |
| " In general, strains were resistant to some of the antimicrobials most frequently used to treat Acinetobacter infections such as piperacillin-tazobactam (64." | 3.85 | Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat. ( Carvalheira, A; Casquete, R; Silva, J; Teixeira, P, 2017) |
| " Population pharmacokinetic analysis and Monte Carlo simulation was undertaken using Pmetrics." | 1.43 | Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients. ( Lefrant, JY; Lipman, J; Louart, B; Muller, L; Roberts, JA; Roger, C; Wallis, SC, 2016) |
| "Levofloxacin (200 mg/kg) was 73% effective, and ciprofloxacin (35 mg/kg) was ineffective in preventing death." | 1.39 | Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptible Acinetobacter baumannii isolates from nosocomial pneumonia patients. ( Davies, TA; He, W; Lynch, AS; Queenan, AM, 2013) |
| "Ciprofloxacin has been found to be effective in the treatment of multidrug-resistant gram negative infections in pediatric patients, including premature infants." | 1.31 | Successful treatment of late onset infection due to multi-drug resistant Acinetobacter Lwoffii in a low birth weight neonate using ciprofloxacin. ( Chotigeat, U; Khorana, M; Waranawat, N, 2001) |
| "Ciprofloxacin and amikacin were somewhat more active than cephalosporins, but resistant isolates were also frequent." | 1.30 | Activity of selected beta-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals. ( Bello, H; Dominguez, M; Garcia, A; Gonzalez, G; Mella, S; Zemelman, R, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (6.94) | 18.2507 |
| 2000's | 24 (33.33) | 29.6817 |
| 2010's | 34 (47.22) | 24.3611 |
| 2020's | 9 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Endimiani, A | 1 |
| Luzzaro, F | 1 |
| Migliavacca, R | 1 |
| Mantengoli, E | 1 |
| Hujer, AM | 1 |
| Hujer, KM | 1 |
| Pagani, L | 1 |
| Bonomo, RA | 1 |
| Rossolini, GM | 1 |
| Toniolo, A | 1 |
| Hu, WS | 1 |
| Yao, SM | 1 |
| Fung, CP | 2 |
| Hsieh, YP | 1 |
| Liu, CP | 2 |
| Lin, JF | 1 |
| Wang, H | 2 |
| Guo, P | 1 |
| Sun, H | 1 |
| Yang, Q | 1 |
| Chen, M | 1 |
| Xu, Y | 1 |
| Zhu, Y | 1 |
| Marti, S | 2 |
| Sánchez-Céspedes, J | 2 |
| Blasco, MD | 1 |
| Ruiz, M | 2 |
| Espinal, P | 1 |
| Alba, V | 1 |
| Fernández-Cuenca, F | 2 |
| Pascual, A | 2 |
| Vila, J | 4 |
| Zarrilli, R | 1 |
| Vitale, D | 1 |
| Di Popolo, A | 1 |
| Bagattini, M | 1 |
| Daoud, Z | 1 |
| Khan, AU | 1 |
| Afif, C | 1 |
| Triassi, M | 1 |
| Adams-Haduch, JM | 1 |
| Paterson, DL | 1 |
| Sidjabat, HE | 1 |
| Pasculle, AW | 1 |
| Potoski, BA | 1 |
| Muto, CA | 1 |
| Harrison, LH | 1 |
| Doi, Y | 1 |
| Bogaerts, P | 1 |
| Cuzon, G | 1 |
| Naas, T | 1 |
| Bauraing, C | 1 |
| Deplano, A | 1 |
| Lissoir, B | 1 |
| Nordmann, P | 1 |
| Glupczynski, Y | 1 |
| Robledo, IE | 1 |
| Aquino, EE | 1 |
| Santé, MI | 1 |
| Santana, JL | 1 |
| Otero, DM | 1 |
| León, CF | 1 |
| Vázquez, GJ | 1 |
| Higgins, PG | 3 |
| Stubbings, W | 1 |
| Wisplinghoff, H | 2 |
| Seifert, H | 4 |
| Lin, YC | 1 |
| Hsia, KC | 1 |
| Chen, YC | 1 |
| Sheng, WH | 1 |
| Chang, SC | 1 |
| Liao, MH | 1 |
| Li, SY | 1 |
| Huang, LY | 1 |
| Lu, PL | 1 |
| Chen, TL | 2 |
| Chang, FY | 2 |
| Siu, LK | 1 |
| Sun, JR | 1 |
| Chan, MC | 1 |
| Chang, TY | 1 |
| Wang, WY | 1 |
| Chiueh, TS | 1 |
| Schneiders, T | 1 |
| Hamprecht, A | 1 |
| Wencewicz, TA | 1 |
| Miller, MJ | 1 |
| Khosravi, AD | 1 |
| Montazeri, EA | 1 |
| Maki, SR | 1 |
| Fuchs, F | 1 |
| Becerra-Aparicio, F | 1 |
| Xanthopoulou, K | 1 |
| Kamoshida, G | 1 |
| Yamada, N | 1 |
| Nakamura, T | 1 |
| Yamaguchi, D | 1 |
| Kai, D | 1 |
| Yamashita, M | 1 |
| Hayashi, C | 1 |
| Kanda, N | 1 |
| Sakaguchi, M | 1 |
| Morimoto, H | 1 |
| Sawada, T | 1 |
| Okada, T | 1 |
| Kaya, Y | 1 |
| Takemoto, N | 1 |
| Yahiro, K | 1 |
| Attia, NM | 1 |
| Elbaradei, A | 1 |
| Casanovas Moreno-Torres, MI | 1 |
| Rodríguez-Campos, F | 1 |
| Gutiérrez-Soto, M | 1 |
| Navarro-Marí, JM | 1 |
| Gutiérrez-Fernández, J | 1 |
| Grygorcewicz, B | 1 |
| Roszak, M | 1 |
| Golec, P | 1 |
| Śleboda-Taront, D | 1 |
| Łubowska, N | 1 |
| Górska, M | 1 |
| Jursa-Kulesza, J | 1 |
| Rakoczy, R | 1 |
| Wojciuk, B | 1 |
| Dołęgowska, B | 1 |
| Mohammed, MA | 1 |
| Ahmed, MT | 1 |
| Anwer, BE | 1 |
| Aboshanab, KM | 1 |
| Aboulwafa, MM | 1 |
| Foletto, VS | 1 |
| da Rosa, TF | 1 |
| Serafin, MB | 1 |
| Bottega, A | 1 |
| Franco, LN | 1 |
| de Paula, BR | 1 |
| Hörner, R | 1 |
| Khuntayaporn, P | 1 |
| Kanathum, P | 1 |
| Houngsaitong, J | 1 |
| Montakantikul, P | 1 |
| Thirapanmethee, K | 1 |
| Chomnawang, MT | 1 |
| Dawan, J | 1 |
| Kim, JC | 1 |
| Ahn, J | 1 |
| Bhattacharyya, T | 1 |
| Sharma, A | 1 |
| Akhter, J | 1 |
| Pathania, R | 1 |
| Tran, GM | 1 |
| Ho-Le, TP | 1 |
| Ha, DT | 1 |
| Tran-Nguyen, CH | 1 |
| Nguyen, TSM | 1 |
| Pham, TTN | 1 |
| Nguyen, TA | 1 |
| Nguyen, DA | 1 |
| Hoang, HQ | 1 |
| Tran, NV | 1 |
| Nguyen, TV | 1 |
| Wang, YC | 1 |
| Huang, TW | 1 |
| Yang, YS | 1 |
| Kuo, SC | 1 |
| Chen, CT | 1 |
| Liu, YM | 1 |
| Wu, SH | 1 |
| How, CK | 1 |
| Lee, YT | 1 |
| Elhosseiny, NM | 1 |
| Elhezawy, NB | 1 |
| Attia, AS | 1 |
| Ušjak, D | 1 |
| Ivković, B | 1 |
| Božić, DD | 1 |
| Bošković, L | 1 |
| Milenković, M | 1 |
| Queenan, AM | 1 |
| Davies, TA | 1 |
| He, W | 1 |
| Lynch, AS | 1 |
| Pavlovic, RR | 1 |
| Jankovic, SM | 1 |
| Gopal, R | 1 |
| Kim, YG | 1 |
| Lee, JH | 1 |
| Lee, SK | 1 |
| Chae, JD | 1 |
| Son, BK | 1 |
| Seo, CH | 1 |
| Park, Y | 1 |
| Traglia, GM | 1 |
| Almuzara, M | 1 |
| Vilacoba, E | 1 |
| Tuduri, A | 1 |
| Neumann, G | 1 |
| Pallone, E | 1 |
| Centrón, D | 1 |
| Ramírez, MS | 1 |
| Blanchard, C | 1 |
| Barnett, P | 1 |
| Perlmutter, J | 1 |
| Dunman, PM | 1 |
| Ardebili, A | 1 |
| Lari, AR | 1 |
| Talebi, M | 1 |
| Jara, LM | 1 |
| Cortés, P | 1 |
| Bou, G | 2 |
| Barbé, J | 1 |
| Aranda, J | 1 |
| Umezawa, K | 1 |
| Asai, S | 1 |
| Ohshima, T | 1 |
| Iwashita, H | 1 |
| Ohashi, M | 1 |
| Sasaki, M | 1 |
| Kaneko, A | 1 |
| Inokuchi, S | 1 |
| Miyachi, H | 1 |
| Roger, C | 1 |
| Wallis, SC | 1 |
| Louart, B | 1 |
| Lefrant, JY | 1 |
| Lipman, J | 1 |
| Muller, L | 1 |
| Roberts, JA | 1 |
| Güler, G | 1 |
| Eraç, B | 1 |
| El-Mahdy, TS | 2 |
| Al-Agamy, MH | 2 |
| Al-Qahtani, AA | 1 |
| Shibl, AM | 2 |
| Jeannot, K | 1 |
| Kattan, W | 1 |
| Plésiat, P | 1 |
| Courvalin, P | 1 |
| Biglari, S | 1 |
| Hanafiah, A | 1 |
| Mohd Puzi, S | 1 |
| Ramli, R | 1 |
| Rahman, M | 1 |
| Lopes, BS | 2 |
| Carvalheira, A | 1 |
| Casquete, R | 1 |
| Silva, J | 1 |
| Teixeira, P | 1 |
| Yang, HY | 1 |
| Lee, HJ | 1 |
| Suh, JT | 1 |
| Lee, KM | 1 |
| Chiu, CH | 1 |
| Lee, HY | 1 |
| Tseng, LY | 1 |
| Chen, CL | 1 |
| Chia, JH | 1 |
| Su, LH | 1 |
| Liu, SY | 1 |
| Coban, AY | 1 |
| Guney, AK | 1 |
| Tanriverdi Cayci, Y | 1 |
| Durupinar, B | 1 |
| López-Rojas, R | 1 |
| Docobo-Pérez, F | 1 |
| Domínguez-Herrera, J | 1 |
| Pachón, J | 2 |
| Medina Presentado, JC | 1 |
| Paciel López, D | 1 |
| Berro Castiglioni, M | 1 |
| Gerez, J | 2 |
| Otero, FM | 1 |
| Santiso, R | 1 |
| Tamayo, M | 1 |
| Fernández, Mdel C | 1 |
| Tomás, M | 1 |
| Gosálvez, J | 1 |
| Fernández, JL | 1 |
| Amyes, SG | 1 |
| Roy, R | 1 |
| Panigrahi, P | 1 |
| Malathi, J | 1 |
| Pal, SS | 1 |
| Nandi, K | 1 |
| Patil, A | 1 |
| Nigam, E | 1 |
| Arora, V | 1 |
| Nikolaidis, P | 1 |
| Metallidis, S | 1 |
| Kollaras, P | 1 |
| Tsona, A | 1 |
| Koumedaki, E | 1 |
| Tsaousoglu, D | 1 |
| Loumedaki, E | 1 |
| Vitkauskiene, A | 1 |
| Sakalauskas, R | 1 |
| Dudzevicius, V | 1 |
| Nejjari, N | 1 |
| Zerhouni, F | 1 |
| Bouharrou, A | 1 |
| Habzi, A | 1 |
| Najdi, T | 1 |
| Lahbabi, M | 1 |
| Benomar, S | 1 |
| Vedantham, V | 1 |
| Miller, J | 1 |
| Di Cataldo, A | 1 |
| La Spina, M | 1 |
| Bertuna, G | 1 |
| Lo Nigro, L | 1 |
| Branciforte, F | 1 |
| Castagnola, E | 1 |
| Medina, J | 1 |
| Formento, C | 1 |
| Pontet, J | 1 |
| Curbelo, A | 1 |
| Bazet, C | 1 |
| Larrañaga, E | 1 |
| Orhan-Sungur, M | 1 |
| Akça, O | 1 |
| Salazar De Vegas, EZ | 1 |
| Nieves, B | 1 |
| Ruíz, J | 1 |
| María, A | 1 |
| Elsa, V | 1 |
| Putcharoen, O | 1 |
| Suankratay, C | 1 |
| Rodríguez-Baño, J | 1 |
| Soto, S | 1 |
| Cisneros, JM | 1 |
| Martínez-Martínez, L | 1 |
| McQueary, C | 1 |
| Actis, LA | 1 |
| Bick, JA | 1 |
| Semel, JD | 1 |
| Bello, H | 1 |
| Gonzalez, G | 1 |
| Dominguez, M | 1 |
| Zemelman, R | 1 |
| Garcia, A | 1 |
| Mella, S | 1 |
| Horrevorts, A | 1 |
| ten Hagen, G | 1 |
| Hekster, Y | 1 |
| Tjernberg, I | 1 |
| Dijkshoorn, L | 1 |
| Martinez, JG | 1 |
| Cambon, S | 1 |
| Rossi, P | 1 |
| Miliani, Y | 1 |
| Arnaud, S | 1 |
| Albanèse, J | 1 |
| Heinemann, B | 1 |
| Edmond, M | 1 |
| Simhon, A | 1 |
| Rahav, G | 1 |
| Shazberg, G | 1 |
| Block, C | 1 |
| Bercovier, H | 1 |
| Shapiro, M | 1 |
| Chotigeat, U | 1 |
| Khorana, M | 1 |
| Waranawat, N | 1 |
| Ermertcan, S | 1 |
| Hoşgör, M | 1 |
| Tünger, O | 1 |
| Coşar, G | 1 |
| Valero, E | 1 |
| Sevillano, D | 1 |
| Calvo, A | 1 |
| García, R | 1 |
| Leturia, A | 1 |
| Gómez-Lus, ML | 1 |
72 other studies available for ciprofloxacin and Acinetobacter Infections
| Article | Year |
|---|---|
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; be | 2007 |
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Base Sequence; beta-Lactamase | 2007 |
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; | 2007 |
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; b | 2008 |
A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; be | 2008 |
Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Base Sequence | 2008 |
Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Belgium; beta-Lactam Resistance; beta-Lactamases; | 2008 |
Detection of KPC in Acinetobacter spp. in Puerto Rico.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; bet | 2010 |
Activity of the investigational fluoroquinolone finafloxacin against ciprofloxacin-sensitive and -resistant Acinetobacter baumannii isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Substitution; Anti-Bacterial Agents; C | 2010 |
Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; beta-Lactamases; Carbapenems; Ce | 2010 |
Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan.
Topics: Acinetobacter; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Cephalosporinase; | 2010 |
Overexpression of the adeB gene in clinical isolates of tigecycline-nonsusceptible Acinetobacter baumannii without insertion mutations in adeRS.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Bacterial Proteins; Carb | 2010 |
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, | 2010 |
Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Agar; Anti-Bacterial Agents; Cephalosporins; Cult | 2013 |
Antibacterial effects of Octenicept, and benzalkonium chloride on Acinetobacter baumannii strains isolated from clinical samples and determination of genetic diversity of isolates by RAPD-PCR method.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Benzalkonium Compounds; Ci | 2021 |
In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin | 2022 |
Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin | 2022 |
Fluoroquinolone resistance conferred by gyrA, parC mutations, and AbaQ efflux pump among Acinetobacter baumannii clinical isolates causing ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carrier Proteins; Ciproflo | 2019 |
[Urinary tract infection by Acinetobacter dijkshoorniae and good clinical response to treatment].
Topics: Acinetobacter; Acinetobacter Infections; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Hu | 2020 |
Antibiotics Act with vB_AbaP_AGC01 Phage against
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacteriolysis; Ba | 2020 |
Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Chlorpromazine; Ciprofloxa | 2020 |
Repositioning of antidepressant drugs and synergistic effect with ciprofloxacin against multidrug-resistant bacteria.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Antidepressive Agents; Bac | 2021 |
Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-L | 2021 |
Insights into collateral susceptibility and collateral resistance in Acinetobacter baumannii during antimicrobial adaptation.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Biological; Anti-Bacterial Agents; be | 2021 |
The small molecule IITR08027 restores the antibacterial activity of fluoroquinolones against multidrug-resistant Acinetobacter baumannii by efflux inhibition.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Biological Transport, Acti | 2017 |
Patterns of antimicrobial resistance in intensive care unit patients: a study in Vietnam.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftaz | 2017 |
Biofilm formation is not associated with worse outcome in Acinetobacter baumannii bacteraemic pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Biofil | 2018 |
Comparative proteomics analyses of Acinetobacter baumannii strains ATCC 17978 and AB5075 reveal the differential role of type II secretion system secretomes in lung colonization and ciprofloxacin resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Bacterial Proteins; Biofilms; Ciprofloxa | 2019 |
Antimicrobial activity of novel chalcones and modulation of virulence factors in hospital strains of Acinetobacter baumannii and Pseudomonas aeruginosa.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective A | 2019 |
Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptible Acinetobacter baumannii isolates from nosocomial pneumonia patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Carbapenems; Ciprofloxacin; Doripenem; D | 2013 |
Inverse correlation of Acinetobacter spp. resistance rate and ciprofloxacin utilization.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bact | 2014 |
Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Antimicrobial Cationic Pep | 2014 |
Bacteremia caused by an Acinetobacter junii strain harboring class 1 integron and diverse DNA mobile elements.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacteremia; Catheter-Related | 2014 |
Identification of Acinetobacter baumannii serum-associated antibiotic efflux pump inhibitors.
Topics: Acetamides; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Biological Tra | 2014 |
Correlation of ciprofloxacin resistance with the AdeABC efflux system in Acinetobacter baumannii clinical isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; ATP-Binding Cassette Trans | 2014 |
Differential roles of antimicrobials in the acquisition of drug resistance through activation of the SOS response in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Ciprofloxacin; Colistin; C | 2015 |
Outbreak of drug-resistant Acinetobacter baumannii ST219 caused by oral care using tap water from contaminated hand hygiene sinks as a reservoir.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; C | 2015 |
Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Ciprofloxacin; Criti | 2016 |
[Investigation of fluoroquinolone resistance mechanisms in clinical Acinetobacter baumannii isolates].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Ciprofloxacin; Cross Infec | 2016 |
Detection of bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial | 2017 |
First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapene | 2017 |
Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapene | 2017 |
Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Animals; Anti-Bacterial Agents; Cattl | 2017 |
Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lact | 2009 |
Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Prot | 2010 |
Effect of 1-(1-Naphtylmethyl)-piperazine, an efflux pump inhibitor, on antimicrobial drug susceptibilities of clinical Acinetobacter baumannii isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Ciprofloxacin; Drug Resist | 2011 |
Pre-clinical studies of a new quinolone (UB-8902) against Acinetobacter baumannii resistant to ciprofloxacin.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Infective Agents; Blood Bactericida | 2011 |
Ceftriaxone and ciprofloxacin restriction in an intensive care unit: less incidence of Acinetobacter spp. and improved susceptibility of Pseudomonas aeruginosa.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Ceftriaxone; Ciprofloxacin; Cross In | 2011 |
Fast assessment of resistance to carbapenems and ciprofloxacin of clinical strains of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Ciprofloxacin; Drug Resistance, Bact | 2012 |
Insertion sequence disruption of adeR and ciprofloxacin resistance caused by efflux pumps and gyrA and parC mutations in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Biological Transport, Acti | 2013 |
Endophthalmitis caused by Acinetobacter baumanni: a case series.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Infective Agents; Cataract Extraction; | 2013 |
In-vitro activity of clinafloxacin compared to ciprofloxacin against Acinetobacter baumannii strains isolated from intensive care unit patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents; Ciprofloxacin; Critical Ca | 2002 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective | 2003 |
[Nosocomial infections caused by Acinetobacter: experience in a neonatal care unit in Casablanca].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cip | 2003 |
Much ado about ciprofloxacin and Acinetobacter.
Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Bacterial Agents; Aqueous Humor; Ciprofl | 2004 |
Acinetobacter as a causative agent in preseptal cellulitis.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Anti-Infective Agents; Cellulitis; Ciprofloxacin; Dr | 2005 |
Spleen and lung involvement by Acinetobacter calcoaceticus bacteremia mimicking deep fungal infection in a child with acute non-lymphoblastic leukemia.
Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Infective Agents; Bacterial Typing Techn | 2006 |
Prospective study of risk factors for ventilator-associated pneumonia caused by Acinetobacter species.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Female; Humans; Inciden | 2007 |
Ventilator-associated pneumonia by multidrug-resistant bacteria: pathogen-specific risks versus care-related risks.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multip | 2007 |
Molecular epidemiology and characterization of resistance mechanisms to various antimicrobial agents in Acinetobacter baumannii isolated in Mérida, Venezuela.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; beta-Lactamases; Ce | 2007 |
Salmonella gas-forming femoral osteomyelitis and pyomyositis: the first case and review of the literature.
Topics: Acinetobacter Infections; Ceftriaxone; Ciprofloxacin; Clindamycin; Cross Infection; Fatal Outcome; H | 2007 |
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; B | 2008 |
Fulminant community-acquired Acinetobacter pneumonia in a healthy woman.
Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Aged; Ciprofloxacin; Drug Resistance, Microbi | 1993 |
Activity of selected beta-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bac | 1997 |
Development of resistance to ciprofloxacin in Acinetobacter baumanii strains isolated during a 20-month outbreak.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Ciprofloxacin; Disease Outbreaks; Drug Resistance, M | 1997 |
Pacemaker pocket infection.
Topics: Acinetobacter Infections; Aged; Anti-Infective Agents; Ciprofloxacin; Humans; Male; Pacemaker, Artif | 1999 |
[Severe agranulocytosis induced by carbamazepine (Tegretol)].
Topics: Acinetobacter Infections; Adult; Agranulocytosis; Analgesics, Non-Narcotic; Anti-Bacterial Agents; A | 1999 |
Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Diseas | 2000 |
Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem, Israel.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin | 2001 |
Successful treatment of late onset infection due to multi-drug resistant Acinetobacter Lwoffii in a low birth weight neonate using ciprofloxacin.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Mult | 2001 |
Investigation of synergism of meropenem and ciprofloxacin against Pseudomonas aeruginosa and Acinetobacter strains isolated from intensive care unit infections.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin | 2001 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; | 2001 |